The University of Queensland, Pharmacy Australia Centre of Excellence, Brisbane, QLD, Australia.
J Drug Target. 2010 Dec;18(10):831-41. doi: 10.3109/1061186X.2010.525651. Epub 2010 Oct 19.
Microencapsulation of a hydrophilic active (gentamicin sulphate (GS)) and a hydrophobic non-steroidal anti-inflammatory drug (ibuprofen) in alginate gel microparticles was accomplished by molecular diffusion of the drug species into microparticles produced by impinging aerosols of alginate solution and CaCl(2) cross-linking solution. A mean particle size in the range of 30-50 µm was measured using laser light scattering and high drug loadings of around 35 and 29% weight/dry microparticle weight were obtained for GS and ibuprofen respectively. GS release was similar in simulated intestinal fluid (phosphate buffer saline (PBS), pH 7.4, 37°C) and simulated gastric fluid (SGF) (HCl, pH 1.2, 37°C) but was accelerated in PBS following incubation of microparticles in HCl. Ibuprofen release was restricted in SGF but occurred freely on transfer of microparticles into PBS with almost 100% efficiency. GS released in PBS over 7 h, following incubation of microparticles in HCl for 2 h was found to retain at least 80% activity against Staphylococcus epidermidis while Ibuprofen retained around 50% activity against Candida albicans. The impinging aerosols technique shows potential for producing alginate gel microparticles of utility for protection and controlled delivery of a range of therapeutic molecules.
通过亲水性活性物质(硫酸庆大霉素 (GS))和疏水性非甾体抗炎药(布洛芬)的分子扩散,将其包封到海藻酸钠凝胶微球中,这些药物通过海藻酸钠溶液和 CaCl2 交联溶液的撞击气溶胶而产生微球。使用激光散射测量得到粒径在 30-50μm 范围内,对于 GS 和布洛芬,载药量分别达到约 35%和 29%(以干微球重量计)。GS 在模拟肠液(磷酸盐缓冲盐水 (PBS),pH 7.4,37°C)和模拟胃液(SGF)(HCl,pH 1.2,37°C)中的释放情况相似,但在将微球孵育在 HCl 中后,在 PBS 中释放速度加快。布洛芬在 SGF 中释放受到限制,但当微球转移到 PBS 中时,释放速度很快,几乎达到 100%的效率。将微球在 HCl 中孵育 2 小时后,在 PBS 中释放 7 小时后,GS 仍保留对表皮葡萄球菌的至少 80%的活性,而布洛芬对白色念珠菌的活性保留约 50%。撞击气溶胶技术显示出用于保护和控制多种治疗分子释放的海藻酸钠凝胶微球的生产潜力。